Literature DB >> 21940507

Echocardiographic variables after left ventricular assist device implantation associated with adverse outcome.

Yan Topilsky1, Tal Hasin, Jae K Oh, Daniel D Borgeson, Barry A Boilson, John A Schirger, Alfredo L Clavell, Robert P Frantz, Rayji Tsutsui, Mingya Liu, Simon Maltais, Sudhir S Kushwaha, Naveen L Pereira, Soon J Park.   

Abstract

BACKGROUND: Operative mortality after left ventricular assist device (LVAD) implantation is heavily influenced by patient selection and the technical difficulty of surgery. However, how we treat our patients and LVAD setting may affect the patient outcome beyond this period. We postulated that the presence of echocardiographic variables 1 month after surgery suggesting appropriate degree of LV unloading and an adequate forward flow would be important in determining clinical outcomes after the initial successful LVAD implantation. METHODS AND
RESULTS: We retrospectively analyzed various variables in echocardiographic examinations performed 30 days after LVAD implant in 76 consecutive patients receiving continuous flow device for their association with a compound end point (90-day mortality, readmission for heart failure, or New York Heart Association class III or higher at the end of the 90-day period). The echocardiographic associations examined included estimated LVAD flow, with and without native LV contribution, interventricular septal position, the status of aortic valve opening, an estimated left atrial pressure (ELAP), the mitral flow E-wave deceleration time, and the ratio of deceleration time to E-wave velocity (mitral deceleration index [MDI]). Four patients died during the 30- to 90-day period, 6 patients were readmitted for heart failure, and 25 patients were considered to have New York Heart Association class III or higher at the end of the 90-day period. Variables associated with adverse outcome included increased ELAP (odds ratio, 1.30 [1.16-1.48]; P<0.0001), MDI <2 ms/[cm/s] (odds ratio, 4.4 implantation [1.22-18]; P=0.02) and decreased tricuspid lateral annulus velocity (odds ratio, 0.70 implantation [0.48-0.95]; P=0.02). A leftward deviation of interventricular septum was associated with a worse outcome (odds ratio, 3.03 implantation [1.21-13.3]; P=0.01).
CONCLUSIONS: Mortality and heart failure after LVAD surgery appear to be predominantly determined by echocardiographic evidence of inefficient unloading of the left ventricle and persistence of right ventricular dysfunction. Increased estimated LA pressure and short MDI are associated with worse mid term outcome. Leftward deviation of the septum is associated with worse outcome as well.

Entities:  

Mesh:

Year:  2011        PMID: 21940507     DOI: 10.1161/CIRCIMAGING.111.965335

Source DB:  PubMed          Journal:  Circ Cardiovasc Imaging        ISSN: 1941-9651            Impact factor:   7.792


  19 in total

Review 1.  Contemporary strategies in the diagnosis and management of heart failure.

Authors:  Shannon M Dunlay; Naveen L Pereira; Sudhir S Kushwaha
Journal:  Mayo Clin Proc       Date:  2014-03-29       Impact factor: 7.616

Review 2.  Predictors and management of right heart failure after left ventricular assist device implantation.

Authors:  Nadia Fida; Matthias Loebe; Jerry D Estep; Ashrith Guha
Journal:  Methodist Debakey Cardiovasc J       Date:  2015 Jan-Mar

3.  Usefulness of the six-minute walk test after continuous axial flow left ventricular device implantation to predict survival.

Authors:  Tal Hasin; Yan Topilsky; Walter K Kremers; Barry A Boilson; John A Schirger; Brooks S Edwards; Alfredo L Clavell; Richard J Rodeheffer; Robert P Frantz; Lyle Joyce; Richard Daly; John M Stulak; Sudhir S Kushwaha; Soon J Park; Naveen L Pereira
Journal:  Am J Cardiol       Date:  2012-07-21       Impact factor: 2.778

4.  Continuous flow left ventricular assist device implant significantly improves pulmonary hypertension, right ventricular contractility, and tricuspid valve competence.

Authors:  Pavan Atluri; Alexander S Fairman; John W MacArthur; Andrew B Goldstone; Jeffrey E Cohen; Jessica L Howard; Christyna M Zalewski; Yasuhiro Shudo; Y Joseph Woo
Journal:  J Card Surg       Date:  2013-09-30       Impact factor: 1.620

Review 5.  Role of Echocardiography in the Evaluation of Left Ventricular Assist Devices: the Importance of Emerging Technologies.

Authors:  Luca Longobardo; Christopher Kramer; Scipione Carerj; Concetta Zito; Renuka Jain; Valentin Suma; Vinay Thohan; Nasir Sulemanjee; Frank X Downey; Bijoy K Khandheria
Journal:  Curr Cardiol Rep       Date:  2016-07       Impact factor: 2.931

6.  Pre-operative echocardiographic features associated with persistent mitral regurgitation after left ventricular assist device implantation.

Authors:  Shuichi Kitada; Tomoko S Kato; Sunu S Thomas; Suzanne D Conwell; Cesare Russo; Marco R Di Tullio; Maryjane Farr; P Christian Schulze; Nir Uriel; Ulrich P Jorde; Hiroo Takayama; Yoshifumi Naka; Shunichi Homma; Donna M Mancini
Journal:  J Heart Lung Transplant       Date:  2013-07-11       Impact factor: 10.247

7.  Minimally invasive and alternative approaches for long-term LVAD placement: the Vanderbilt strategy.

Authors:  Simon Maltais; Mary E Davis; Nicholas Haglund
Journal:  Ann Cardiothorac Surg       Date:  2014-11

Review 8.  The practical role of echocardiography in selection, implantation, and management of patients requiring LVAD therapy.

Authors:  Maria Chiara Todaro; Bijoy K Khandheria; Timothy E Paterick; Matt M Umland; Vinay Thohan
Journal:  Curr Cardiol Rep       Date:  2014-04       Impact factor: 2.931

9.  Development of a novel echocardiography ramp test for speed optimization and diagnosis of device thrombosis in continuous-flow left ventricular assist devices: the Columbia ramp study.

Authors:  Nir Uriel; Kerry A Morrison; Arthur R Garan; Tomoko S Kato; Melana Yuzefpolskaya; Farhana Latif; Susan W Restaino; Donna M Mancini; Margaret Flannery; Hiroo Takayama; Ranjit John; Paolo C Colombo; Yoshifumi Naka; Ulrich P Jorde
Journal:  J Am Coll Cardiol       Date:  2012-10-03       Impact factor: 24.094

10.  Early Right Ventricular Assist Device Use in Patients Undergoing Continuous-Flow Left Ventricular Assist Device Implantation: Incidence and Risk Factors From the Interagency Registry for Mechanically Assisted Circulatory Support.

Authors:  Michael S Kiernan; E Wilson Grandin; Marshall Brinkley; Navin K Kapur; Duc Thinh Pham; Robin Ruthazer; J Eduardo Rame; Pavan Atluri; Edo Y Birati; Guilherme H Oliveira; Francis D Pagani; James K Kirklin; David Naftel; Robert L Kormos; Jeffrey J Teuteberg; David DeNofrio
Journal:  Circ Heart Fail       Date:  2017-10       Impact factor: 8.790

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.